PMC:7195088 / 65192-65411 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7195088","sourcedb":"PMC","sourceid":"7195088","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7195088","text":"In the absence of clinical studies, we suggest that also other immunosuppressive and/or immunomodulatory therapies (e.g. anakinra, Janus kinase family enzyme inhibitors) should be preferentially administered within RCT.","tracks":[{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T89792","span":{"begin":151,"end":168},"obj":"Chemical"},{"id":"T91905","span":{"begin":158,"end":168},"obj":"Chemical"}],"attributes":[{"id":"A80616","pred":"chebi_id","subj":"T89792","obj":"http://purl.obolibrary.org/obo/CHEBI_23924"},{"id":"A25044","pred":"chebi_id","subj":"T91905","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"subj":"T89792","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T91905","pred":"source","obj":"LitCovid-PD-CHEBI"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T464","span":{"begin":0,"end":219},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T464","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-CHEBI","color":"#ccec93","default":true},{"id":"LitCovid-sentences","color":"#ec93e6"}]}]}}